HIBBS KATHY L
SEC Form 4 insider trading activity
HIBBS KATHY L has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including SOPH, LAB, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Sep 10, 2026.
On the most recent filing, HIBBS KATHY L is listed as Director at SOPHiA GENETICS SA. Inside the rolling window, HIBBS KATHY L reported no open-market purchases and 3 open-market sales totaling $140K in SOPH. The largest disclosed transaction in the window is a sale of 6,250 SOPH shares on Aug 25, 2026, worth $54K.
Companies traded
Other insiders at SOPH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$140K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has HIBBS KATHY L made?
HIBBS KATHY L has filed 5 SEC Form 4 filings (5 transaction rows) across 2 companies, including SOPH, LAB since 2026.
Which companies does HIBBS KATHY L trade?
HIBBS KATHY L has filed SEC Form 4 disclosures for 2 companies, including SOPH, LAB.
When was HIBBS KATHY L's most recent SEC Form 4 filing?
HIBBS KATHY L's most recent SEC Form 4 filing on Tracefour is dated Sep 10, 2026.
What is HIBBS KATHY L's total buy and sell value in the current window?
Inside the rolling retention window, HIBBS KATHY L bought $0 and sold $140K based on SEC Form 4 filings.
What was HIBBS KATHY L's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,250 SOPH shares on 2026-08-25, worth $54K, per SEC Form 4 filings.